It’s all catching up to Jeff.... https://finance.yahoo.com/news/elan-investor-alert-bernstein-liebhard-220200672.html
Fort Dodge animal health and Novartis animal health were doing fine. This is what happens when you overpay for assets for growth sake, you blame everyone but yourself for poor performance.
No no no... they were not really doing fine. Due diligence failure here and large over-payment. Same same with BI for Merial, cost Joachim's seat. Now Bayer. Will this be a strike three?
If you were to go back before the financial crisis of 2008, Fort Dodge’s revenue growth was consistently over 10 percent. Go to seeking alpha and look at the earnings transcripts. Keep in mind, Wyeth sold shortly after the financial crisis hit. Distributor margins on the vaccines were much better. Both companion as well as equine.
